Insider · CIK 0001465272

Molly Montgomery

Reports to the SEC for 6 companies · MILL VALLEY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001465272

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-18	Benson Hill, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,352 sh	—	—	6,481
2024-07-18	Benson Hill, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,352 sh	—	—	0
2024-07-18	Benson Hill, Inc.Restricted Stock UnitsA Award	Director	AAward	+10.7K sh	—	—	10,675
2023-09-29	Benson Hill, Inc.S Sale	Director	SSale	−8,484 sh	$0.33	−$2,813.294	74,529
2023-09-29	Benson Hill, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+22.3K sh	—	—	83,013
2023-09-29	Benson Hill, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−22.3K sh	—	—	0
2023-08-11	Benson Hill, Inc.Restricted Stock UnitsA Award	Director	AAward	+152K sh	—	—	152,334
2023-07-03	Benson Hill, Inc.S Sale	Director	SSale	−23.5K sh	$1.24	−$29.2K	60,686
2023-07-01	Benson Hill, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+61.9K sh	—	—	84,196
2023-07-01	Benson Hill, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−61.9K sh	—	—	0
2023-05-23	TYGOTIGO ENERGY, INC. · Warrants to purchase common stockS Sale	former director	SSale	−2,099 sh	—	—	185
2023-05-23	TYGOTIGO ENERGY, INC.S Sale	former director	SSale	−20.5K sh	—	—	12,549
2022-09-29	Benson Hill, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−22.3K sh	—	—	22,327
2022-09-29	Benson Hill, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+22.3K sh	—	—	22,327
2022-07-01	Benson Hill, Inc.Restricted Stock UnitsA Award	Director	AAward	+61.9K sh	—	—	61,869
2021-12-09	Benson Hill, Inc.Restricted Stock UnitsA Award	Director	AAward	+44.7K sh	—	—	44,654
2021-12-09	Benson Hill, Inc.Restricted Stock UnitsA Award	Director	AAward	+44.7K sh	—	—	44,654
2021-08-10	TYGOTIGO ENERGY, INC. · Warrants to purchase Common StockP Purchase	former director	PPurchase	+2,284 sh	—	—	2,284
2021-08-10	TYGOTIGO ENERGY, INC.P Purchase	former director	PPurchase	+4,569 sh	$10.00	+$45.7K	33,034
2021-03-05	QualTek Services Inc.P Purchase	Director	PPurchase	+5,000 sh	$10.00	+$50K	40,233
2021-03-05	QualTek Services Inc.Warrants to purchase Common StockP Purchase	Director	PPurchase	+1,250 sh	—	—	1,250
2020-12-15	RSVRReservoir Media, Inc. · Warrants to purchase Common StockP Purchase	Director	PPurchase	+3,849 sh	—	—	3,849
2020-12-15	RSVRReservoir Media, Inc.P Purchase	Director	PPurchase	+7,699 sh	$10.00	+$77K	88,189
2020-05-07	Roth CH Acquisition I CoWarrants to purchase Common StockP Purchase	Director	PPurchase	+7,500 sh	—	—	7,500
2020-05-07	Roth CH Acquisition I CoP Purchase	Director	PPurchase	+10K sh	$10.00	+$100K	85,658
2019-06-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−7,592 sh	$9.55	−$72.5K	7,592
2019-06-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Chief Executive Officer	FTax Payment	−3,764 sh	$9.55	−$35.9K	184,053
2019-06-06	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+7,592 sh	$9.55	+$72.5K	187,817
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−71.6K sh	$9.35	−$669K	71,575
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+71.6K sh	$9.35	+$669K	179,765
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Chief Executive Officer	FTax Payment	−24.8K sh	$9.35	−$231K	155,015
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−71.6K sh	$9.35	−$669K	71,575
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+71.6K sh	$9.35	+$669K	204,974
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Chief Executive Officer	FTax Payment	−24.8K sh	$9.35	−$232K	180,159
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−71.6K sh	$9.35	−$669K	71,574
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Chief Executive Officer	FTax Payment	−24.8K sh	$9.35	−$231K	180,225
2019-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+71.6K sh	$9.35	+$669K	204,975
2018-10-20	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−23.7K sh	—	—	0
2018-10-20	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+23.7K sh	$14.11	+$334K	119,941
2018-10-20	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Chief Executive Officer	FTax Payment	−11.8K sh	$14.11	−$166K	108,190
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Nonqualified Stock Option (Right to Buy)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+35.5K sh	$14.35	+$510K	560,532
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+22.8K sh	—	—	22,794
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Right to Buy Restricted Stock Unit (RSU)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+14.2K sh	—	—	14,167
2018-07-25	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Incentive Stock Option (Right to Buy)M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+6,968 sh	$14.35	+$100K	567,500
2018-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Chief Executive Officer	FTax Payment	−24.8K sh	$14.05	−$348K	96,238
2018-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+50K sh	$14.05	+$703K	121,028
2018-05-28	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	0
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\F Tax Payment	Chief Executive Officer	FTax Payment	−24.8K sh	$13.65	−$338K	71,028
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\ · Restricted Stock UnitM Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	50,000
2018-05-23	LFCRLIFECORE BIOMEDICAL, INC. \DE\M Exercise/Conversion	Chief Executive Officer	MExercise/Conversion	+50K sh	$13.65	+$683K	95,818

Recent filings

Accepted (ET)
Aug 14
Molly Montgomery0001830210-24-000105
SEC(opens sec.gov)
Oct 34
Molly Montgomery0001830210-23-000174
SEC(opens sec.gov)
Aug 154
Molly Montgomery0001830210-23-000160
SEC(opens sec.gov)
Jul 54
Molly Montgomery0001830210-23-000128
SEC(opens sec.gov)
May 254
Molly Montgomery0001104659-23-064793
SEC(opens sec.gov)
Oct 34
Molly Montgomery0001830210-22-000172
SEC(opens sec.gov)
Jul 64
Molly Montgomery0001830210-22-000133
SEC(opens sec.gov)
Dec 144
Molly Montgomery0001830210-21-000020
SEC(opens sec.gov)
Dec 144/A
Molly Montgomery0001830210-21-000023
SEC(opens sec.gov)
Aug 114
Molly Montgomery0001104659-21-103560
SEC(opens sec.gov)
Mar 84
Molly Montgomery0001104659-21-033292
SEC(opens sec.gov)

Companies

Address

739 MILLER AVENUE

MILL VALLEY, CA, 94941